Return-Path: Received: from cloud.mkt.tools by cloud.mkt.tools with LMTP id cdizCuP1H2ezuR0AaNiWHg (envelope-from ); Mon, 28 Oct 2024 17:36:51 -0300 Return-path: Envelope-to: renata@bewonderful.com.br, estudio@bewonderful.com.br Delivery-date: Mon, 28 Oct 2024 17:36:51 -0300 Received: from mail-dm6nam11on2045.outbound.protection.outlook.com ([40.107.223.45]:57281 helo=NAM11-DM6-obe.outbound.protection.outlook.com) by cloud.mkt.tools with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384 (Exim 4.97.1) (envelope-from ) id 1t5WTZ-00000008Aks-2c1m; Mon, 28 Oct 2024 17:36:51 -0300 ARC-Seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none; b=pSOrAMDqvih+rIOw1bPnIqFGXjoKm5hA9ByGaS/78OesCxLXvGcDkLapbdLuIxxw+jG3k8viFNslG6piFepqQGcbq82kcDVf8oN3EQIahGCGS9pAQsLM4FwLeStMYAO9DD8l1zVX63WvAT81KhCX2BXHytIEvV+n9s6teCuTaThTEFbSs+0HISpn0294C0N9jzY8B8lliajLg9wMwbpsaHDpiy/T9o3D2yNX8T8cxT6yQgEH/b6VoS8jbatJtIxnOqb4qqm/mk0scgtBOVS12R6HtY5co5vUckdr300UFQTR35v7wc6SRv23eyejDqVvMkoqdI0/pJjzmVUGoSJ+fg== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=sAs/4uZ4bykG47RX2UiAa6gjDjNQ6tH37x7NTLAMFME=; b=yc29UrB13trkN+TRYbJwy5DoZoMMoquZVSdCSWHrhnKZv2pfNNOaLiJJFrBqdwXR2EAqso1DTfUfGzdqgeddksLc3SvdrsU5FZ1wB3F03mNkrmDqwv8LWK7/n5aCa2pD845jA/5r+ADTqUG7LS80g9Gm0hfi+anP39ranoecPUFGy8LB7LSHtnKrsX7mEimj1/e4+gYZxLnsfV7f8xmegSceSCcy3H4fndSM6tYwhR3KXf0bfcBC5ZyCkiTuV9HC+8pokusCbTNuM51bkBKhO/mCmWqFIBNmPBdxQoqWDJvc2Paqd1ldkIm5J0BNUhfky58RmY1Ulk3qWr4YbHQ42w== ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=pass smtp.mailfrom=hypera.com.br; dmarc=pass action=none header.from=hypera.com.br; dkim=pass header.d=hypera.com.br; arc=none DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=hypera.com.br; s=selector1; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=sAs/4uZ4bykG47RX2UiAa6gjDjNQ6tH37x7NTLAMFME=; b=QyXLuDMbN4LXoc2SdMcm970t2MEH5HyMMmkRazOVaMvng2C6UuJ+86LI3zhmZ4CaYjo7Hw9QrHjdk5rou5+QtyEHJB0oU9yJviRXw7V5Jn3+QuS+DVG3wrnradM4MG/xjrCeq9w2VC+ykTPEE8qU89u6T2Aujre6MOpwbKr4MgDqCtpQG6iO25cn6QnluhYBD5MX76HtI+LfbXxMh4vFFTQ1ZvWLjrBrzFOIoFyD1Do0imxQ6dXgk+zLNvlH1v31TcEaaof0DwoLYyF2gka+7+rf9tK5hhzQmn9CIV07/T9voaIQQh7LdQ8TM4aX4Q71IhEWYt1A/Hw/ld1CMxeulA== Received: from CPUP152MB4450.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:d2::12) by RO2P152MB4618.LAMP152.PROD.OUTLOOK.COM (2603:10d6:10:69::5) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8093.25; Mon, 28 Oct 2024 20:35:34 +0000 Received: from CPUP152MB4450.LAMP152.PROD.OUTLOOK.COM ([fe80::75f7:3cc8:2231:8cd4]) by CPUP152MB4450.LAMP152.PROD.OUTLOOK.COM ([fe80::75f7:3cc8:2231:8cd4%3]) with mapi id 15.20.8093.021; Mon, 28 Oct 2024 20:35:34 +0000 From: Gabriel Rocha Hora To: Renata de Cristofaro CC: =?iso-8859-1?Q?Est=FAdio_Wonderful?= Subject: =?iso-8859-1?Q?RES:_Aceleradores_Neo_Pharma_Excel=EAncia_Novembro?= Thread-Topic: =?iso-8859-1?Q?Aceleradores_Neo_Pharma_Excel=EAncia_Novembro?= Thread-Index: AQHbKXjeg5T13l1YlkyD7CJUaPre87KcntuQ Date: Mon, 28 Oct 2024 20:35:34 +0000 Message-ID: References: In-Reply-To: Accept-Language: pt-BR, en-US Content-Language: pt-BR X-MS-Has-Attach: X-MS-TNEF-Correlator: authentication-results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=hypera.com.br; x-ms-publictraffictype: Email x-ms-traffictypediagnostic: CPUP152MB4450:EE_|RO2P152MB4618:EE_ x-ms-office365-filtering-correlation-id: b6582a6c-27e8-4a32-3339-08dcf79012b5 x-ms-exchange-atpmessageproperties: SA x-ms-exchange-senderadcheck: 1 x-ms-exchange-antispam-relay: 0 x-microsoft-antispam: BCL:0;ARA:13230040|1800799024|366016|376014|69100299015|8096899003|38070700018; x-microsoft-antispam-message-info: =?iso-8859-1?Q?ABEpdutGxlLOTA9OxIbsHjMruI0WLLrAT7hg1jugTCAFY2Zx0cOpM7rl9L?= =?iso-8859-1?Q?6/0HCMhOwbedEo3cGwWgaXlc14kjTnDd3Agw5hz7E+1GUeVkWPNir2zqNu?= =?iso-8859-1?Q?jKZzt7IFWYNob0B7qaRfg5Om5Zq0y6f2pfyg7RHvClpIWMGuB6RFOb+BwF?= =?iso-8859-1?Q?8zfctmGDluGGgaVL4wg0xCEMMbVXhPTR7gZAUP9V3VPpQDFhxipxaOEQ/C?= =?iso-8859-1?Q?ReZxwpNV64KP9VWqgoFO3pNmSoE3nkp1ydD2hNqi3KOMZcL595nR+uglCx?= =?iso-8859-1?Q?R3tsIa1xiR67GIl7kWxXfu8U8Go/HaVDOCH5hYArP7YI8dRj1sxCV0lCew?= =?iso-8859-1?Q?WpT7YVF9BDgcl+YOlwOMqcAsyJ5O6gxFv5Flto5w1T8eHC4KtyhkDEy4XH?= =?iso-8859-1?Q?hr5ndDl6R2ZKwCbb2yjKkly3gxj56VqwBbmqGRu8JZZU9elbRjzKUNXvDg?= =?iso-8859-1?Q?JwqtK8OKzFqs7it0rkcTlt/7wkKTv3YF8vFQi5Ny/zUDHD/9SJvOJgQYeV?= =?iso-8859-1?Q?pStH+4n303lMV8UHIQF84fERukeBJlFMSoZ+YV6Mu5+0mwMbWc+2XNoz64?= =?iso-8859-1?Q?9aSrBoVb+ZLtYMYfZqDhqKudyplTGGJ/ewgG7RWfCO64kqB9DxD6SstXMn?= =?iso-8859-1?Q?4uyXAiyBc/41YvklBprHjTy762wj/rTEcFQoNcEZ28v2VZsTn/B7NMgdrG?= =?iso-8859-1?Q?GLPTMYi7Ckt9GeDY8x+pw463awKQbsuTf3PbDmZgbkKmNLheMGJYDuYWvt?= =?iso-8859-1?Q?wfYnjMZ1iYUsJsQIaYT4vAmvHgVM3xH1+ztevwz0mpTrsBBfViGDAqD+Hy?= =?iso-8859-1?Q?krZXRegcfJEBguBcuunlODIOjc+89GE7QnizL9pTBp7kODthdnd0YSDePk?= =?iso-8859-1?Q?vwC3odJQ+nmggOQZnGr38ZWwQrCpO3SRp7+CS9j1v4jMDqJ253L0KSSJBD?= =?iso-8859-1?Q?uBJzPCtU5BRk+GU3la00Q9B+xsR3++8V4G39TMSIcH7Oi4NgAWT8NkoxPj?= =?iso-8859-1?Q?6SWruS23nKqU19Euylgx50iq2qKDK6e7kt6EFnQwgxYwxqywvhxcQ0ENDN?= =?iso-8859-1?Q?9Z8mrL7MN6urh8LdHvy4kY47UWaTqf5/sn62laqrDRCGwso5RH7HejaZE0?= =?iso-8859-1?Q?DlTCR2+8c8u9rxlZoAb8fxI9BHBMpBYSoCPGTcnv/c70Kn3ezdGvj6zbUW?= =?iso-8859-1?Q?N0B1csXUN+zBM53NlLkpEalHQHJ8UxEaDhMnW+UUrOdAk+2hq3Ajm7QIGu?= =?iso-8859-1?Q?3Vgt9BMeJ7VTY36tWZgtIIW8XM38D1kPN3XpGsXiflQS7OKJSprGE8zNZi?= =?iso-8859-1?Q?IKR0Rl3aZffoCHriXvMwESaHd7uKVWRg1k4NP0jK1cU/Fv0geVn++ZXqHw?= =?iso-8859-1?Q?TQ6kmH9F25?= x-forefront-antispam-report: CIP:255.255.255.255;CTRY:;LANG:pt;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:CPUP152MB4450.LAMP152.PROD.OUTLOOK.COM;PTR:;CAT:NONE;SFS:(13230040)(1800799024)(366016)(376014)(69100299015)(8096899003)(38070700018);DIR:OUT;SFP:1101; x-ms-exchange-antispam-messagedata-chunkcount: 1 x-ms-exchange-antispam-messagedata-0: =?iso-8859-1?Q?7ZJokcQPN+5xiSYMVmYtSRC74hIs4s9dDnNdnVkldFG2uBc2XeW0ThBTUV?= =?iso-8859-1?Q?I5EZWLjIjXPddGTOE0D4dD/dMaqGa1ILWlUmhg5reFq/RWxxis86GnbO8k?= =?iso-8859-1?Q?jPKOYezO5tghx4uyPii8vO6DCSC/AXgu5QfjVL44Xmq55l/V1/NlKJZJQz?= =?iso-8859-1?Q?ULubbG7gdwB3e149GUaQwsd5IQfvOIqfbkYYNi3znjOZhyBAAufMfKMlQq?= =?iso-8859-1?Q?seE+V2yCTWz10dvN/K6DJhvrtISYDf/r0oCjdb+f2PZKltavDqD/PL1ddr?= =?iso-8859-1?Q?/bb1jxPKOkl5XptB/CNLujeqbT6OIMOc4DZi2ZSrLTaYYQ0mxmnsyq/ixm?= =?iso-8859-1?Q?w/JnU9/xacPXMdAQyGpEHXDyQX1P0ADMND6qM78t8Awq6ExbG8fzRrATZy?= =?iso-8859-1?Q?MGoPx8WtmPVthCNzxCTh/VyO2zo8zzVApeSO+MFoWc3MMkIInWHHHCj14n?= =?iso-8859-1?Q?1TG+VgiLgD4e4KnefEmbSGPUA0Xkif5tUcb/IuYjigAPkdyrCnNGvHifgL?= =?iso-8859-1?Q?ZW7zGKoASAL0v2UDooy5NOyIQ7VRdDahqVzU+F73ZZh7DSGE8Z4/sZhTGg?= =?iso-8859-1?Q?c/B3i/7rhg8bkr0X4zX0PLcAsFzZWmtKTo/3diVIf7IyHOuFqV0Scz0+DC?= =?iso-8859-1?Q?GOp/n4Qp9jRYq6YLMKi8Vg5r01RWb16ucmxTmA6Gras6Mon7xC5vFMnNYF?= =?iso-8859-1?Q?gTylTMB9iyVIzVv5CBnPo2RFIA9RDS6Wr3QsTBSibwmQKi5ZJyl0/vxUh9?= =?iso-8859-1?Q?mNWF6gr53bFfPPoxd1duJ/r1HNnXj/hfNzRL3W5lQSGO8lIK9msTTJY/P+?= =?iso-8859-1?Q?3klDGnSUoE2ovvhXEyMDn5AyMLcv2xuDrImgAMazYTzPRRv5OgRdoSo32s?= =?iso-8859-1?Q?zHWhskn5NGd+qak9AV8ZuoYjcwYUuo5afa5BqCVFYj7SvFzWaDuq3Scd0F?= =?iso-8859-1?Q?/H8hQUsJo2B89YZpf5nZRZUHVU316rmuWDFZyUQhpb4U8HrlB1ZOa0DLQU?= =?iso-8859-1?Q?gV7JKdztEr3k8TJThK/lecZcuEnmxckgr2+hW4u+SyEYcaitTz1rP9K+Ab?= =?iso-8859-1?Q?e22JlW6JysU32RB6RcPxuK7JqfcMbEq6C8UL5ET3Z3RudFaZeLbZXrg/gZ?= =?iso-8859-1?Q?pdmLLMnVGnNq1NATnW2JumpVS2z3RghFhYhOiF7Z1rpNUM6JFjuEPvPW01?= =?iso-8859-1?Q?WJj+nxR2wovUo9RJ2mADq4ry+KfA4YFPVsDgNB9uE+gxFZalV2/uQCZ1xF?= =?iso-8859-1?Q?7kijN7LjZMe9sSmMGx2mlymqmYrSU1QcD9cZGFMOlnMGLR/WBc4eb3EuCK?= =?iso-8859-1?Q?vPFEdwQlMNoFhlY1PbwgPqgLv6ThHKjdPzWmgffxzuQLa6zFbHOsqztHui?= =?iso-8859-1?Q?h7bHwhOk+NM7pO6MfNb4GVVlyYrK0VyU2qkK9A9bjjqGsux31tl0MlHOds?= =?iso-8859-1?Q?9E9eOFD1zjKvyl9kiotWKL025NvlXZN2tBmGyD/Nrj5N3BJGJYtCwa8qtD?= =?iso-8859-1?Q?8UEjJyvX2qo09DeyL0YR2MkcHuHRuikyXp64CTPQAcew/iDl/0rkH2Nizo?= =?iso-8859-1?Q?S6NaJexh9lfULaG0WOz3ooGy0cWuRGObdUdF7FikRCuJBV4cCd+c5+CG2L?= =?iso-8859-1?Q?coVPS/SH8rAJCyObj0xBsGUM5G/Nav/u6k?= Content-Type: multipart/alternative; boundary="_000_CPUP152MB445030F4768872701D5B1B9AD04A2CPUP152MB4450LAMP_" MIME-Version: 1.0 X-OriginatorOrg: hypera.com.br X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-AuthSource: CPUP152MB4450.LAMP152.PROD.OUTLOOK.COM X-MS-Exchange-CrossTenant-Network-Message-Id: b6582a6c-27e8-4a32-3339-08dcf79012b5 X-MS-Exchange-CrossTenant-originalarrivaltime: 28 Oct 2024 20:35:34.0804 (UTC) X-MS-Exchange-CrossTenant-fromentityheader: Hosted X-MS-Exchange-CrossTenant-id: 3f7a3df4-f85b-4ca8-98d0-08b1034e6567 X-MS-Exchange-CrossTenant-mailboxtype: HOSTED X-MS-Exchange-CrossTenant-userprincipalname: BMjEjGu9m/a6GNvhJjKVBCKFgKyTzQwpbCym4VB1RswPqWhj+Vf/ptFkKy3ZXt7P2Oi8YQgm6aYTKVPPTabxTW+PMmMSkNqJaWdHITfeXS8= X-MS-Exchange-Transport-CrossTenantHeadersStamped: RO2P152MB4618 X-Spam-Status: No, score=2.7 X-Spam-Score: 27 X-Spam-Bar: ++ X-Ham-Report: Spam detection software, running on the system "cloud.mkt.tools", has NOT identified this incoming email as spam. The original message has been attached to this so you can view it or label similar future email. If you have any questions, see root\@localhost for details. Content preview: Boa tarde, Sim, pode seguir. Att Content analysis details: (2.7 points, 10.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- -0.0 SPF_HELO_PASS SPF: HELO matches SPF record 0.0 T_SPF_TEMPERROR SPF: test of record failed (temperror) 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid -0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from envelope-from domain -0.1 ARC_VALID Message has a valid ARC signature -0.1 DKIM_VALID Message has at least one valid DKIM or DK signature 0.0 ARC_SIGNED Message has a ARC signature -0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from author's domain 0.0 HTML_MESSAGE BODY: HTML included in message 3.0 FORGED_SPF_HELO No description available. X-Spam-Flag: NO --_000_CPUP152MB445030F4768872701D5B1B9AD04A2CPUP152MB4450LAMP_ Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Boa tarde, Sim, pode seguir. Att De: Renata de Cristofaro Enviada em: segunda-feira, 28 de outubro de 2024 17:35 Para: Gabriel Rocha Hora Cc: Est=FAdio Wonderful Assunto: Re: Aceleradores Neo Pharma Excel=EAncia Novembro E-MAIL EXTERNO: Esta mensagem foi enviada de fora da organiza=E7=E3o. Somen= te clique em links ou abra anexos se tiver certeza que s=E3o seguros e o re= metente confi=E1vel. Na d=FAvida, encaminhe a mensagem para seguranca.infor= macao@hypera.com.br Oi, Gabbs! Boa tarde. Tudo bem, obrigada. Obrigada por compartilhar. PS: Vamos seguir com o KV de Black Friday - ou seguimos no padr=E3o mesmo? Aguardo seu retorno, Obrigada, Bj, Renata de Cristofaro Account Manager +55 (11) 4280-8811 +55 (11) 98383-8844 renata@bewonderful.com.br www.bewonde= rful.com.br AG=CANCIA WONDERFUL marketing comunica=E7=E3o promo=E7=E3o incentivo digital social Alameda Rio Negro, 585 Bloco A 8 andar Barueri SP Brasil Cep 064= 54-000 Pense no MEIO AMBIENTE antes de imprimir. Voc=EA realmente precisa de uma c= =F3pia impressa? -------- Mensagem respondida -------- Assunto: Aceleradores Neo Pharma Excel=EAncia Novembro Data: Mon, 28 Oct 2024 17:14:03 -0300 De: Gabriel Hora < gabriel.hora@hypera.com.br > Para: renata@bewonderful.com.br Cc: estudio@bewonderful.com.br Boa tarde Renata, Tudo bem? Seguem os aceleradores de Novembro Neo Pharma Excel=EAncia. Acelerador prim=E1rio: Vitaminas NQ =3D 45 unidades ganha 10 pontos Aceleradores Secund=E1rios: Bronfe + Fenil Compre 10 unidades de ganhe 10 pontos Limitador: 150 pontos R$ 1/ unidade Levanlodipino Compre 5 unidades de ganhe 10 pontos Limitador: 100 pontos R$ 2/ unidade Muito Obrigado, Gabriel Hora Hypera Pharma ? Similares e Gen=E9ricos Analista de Trade Marketing ? Canal Indireto gabriel.hora@hypera.com.br [https://www.mkt.tools/tracker/tagTracker.php?client=3DZDI5dVpHVnlablZz&id_= sys_app=3DTVRVPQ=3D=3D&id_sys_flag=3DTnc9PQ=3D=3D&id_app_id=3DTmpjeFptWTFOb= UZrWXpWa05RPT0=3D&id_cnt_contact_in=3DTXc9PQ=3D=3D&id_cnt_contact_out=3DTXp= FNU5EST0=3D] --_000_CPUP152MB445030F4768872701D5B1B9AD04A2CPUP152MB4450LAMP_ Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable

Boa tarde,

 

Sim, pode seguir.

 

Att

 

 

De: Renata de Cristofaro <renata@bewonderful.com.b= r>
Enviada em: segunda-feira, 28 de outubro de 2024 17:35
Para: Gabriel Rocha Hora <gabriel.hora@hypera.com.br>
Cc: Est=FAdio Wonderful <estudio@bewonderful.com.br>
Assunto: Re: Aceleradores Neo Pharma Excel=EAncia Novembro

 

E-MAIL EXTERNO: Esta mensagem foi e= nviada de fora da organiza=E7=E3o. Somente clique em links ou abra anexos se tiver certeza que s=E3o seguros e o remetente confi=E1vel. = Na d=FAvida, encaminhe a mensagem para seguranca.informacao@= hypera.com.br

 

Oi, Gabbs!

 

Boa tarde. Tudo bem, obrigada.

Obrigada por compartilhar.

 

PS: Vamos seguir com o KV de Black Friday - ou seguimos no padr=E3o mesm= o?

 

Aguardo seu retorno,

Obrigada,

 

Bj,

Renata de Cristofar= o
Account Manager

 


+55 (11) 4280-8811     +55 (11) 98383-8844
renata@bewonderful.com.br =     www.bewonderful.com.br

AG=CANCIA WONDERFUL
marketing   comunica=E7=E3o   promo=E7=E3o   = incentivo   digital   social

Alameda Rio Negro, 585   Bloco A   8 andar   Barue= ri SP    Brasil   Cep 06454-000
Pense no MEIO AMBIENTE antes de imprimir. Voc=EA realm= ente precisa de uma c=F3pia impressa?





-------- Mensagem respondida --------

Assunt= o:

Aceleradores Neo Pharma Excel=EAncia Novembro

Data:<= /b>

Mon, 28 Oct 2024 17:14:03 -0300

De:

Gabriel Hora < gabriel.hora@hypera.com.br >

Para:<= /b>

renata@= bewonderful.com.br

Cc:

estudi= o@bewonderful.com.br



Boa tarde Renata,

Tudo bem?

 

Seguem os aceleradores de Novembro Neo Pharma Exc= el=EAncia.

 

Acelerador prim=E1rio:

Vitaminas NQ =3D 45 unidades ganha 10 pontos

 

Aceleradores Secund=E1rios:

 

 Bronfe + Fenil

 Compre 10 unidades de ganhe 10 ponto= s

Limitador: 150 pontos

R$ 1/ unidade

 

 

 Levanlodipino

 Compre 5 unidades de ganhe 10 pontos=

Limitador: 100 pontos

R$ 2/ unidade

 

Muito

Obrigado,

 

Gabriel Hora
Hypera Pharma ? Similares e Gen=E9ricos
Analista de Trade Marketing ? Canal Indireto
gabri= el.hora@hypera.com.br

 

 

--_000_CPUP152MB445030F4768872701D5B1B9AD04A2CPUP152MB4450LAMP_--